tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Celularity Issues Promissory Note and Warrant

Story Highlights
  • Celularity issued a $6.8 million promissory note and a warrant for 3.7 million shares.
  • The note will help settle a loan, impacting Celularity’s operations and market position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Celularity Issues Promissory Note and Warrant

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Celularity ( (CELU) ).

On July 21, 2025, Celularity Inc. issued a promissory note worth $6,812,230 to an investor, along with a warrant to purchase 3,700,000 shares of Class A common stock at $2.528 per share, exercisable for five years. The note, bearing a 2% annual interest rate and maturing on March 21, 2026, is secured by the company’s assets and will be partially used to settle a loan from C.V. Starr & Co. This financial maneuver is expected to impact Celularity’s operations by addressing existing debt obligations and potentially influencing its market positioning.

Spark’s Take on CELU Stock

According to Spark, TipRanks’ AI Analyst, CELU is a Neutral.

The stock’s overall score is driven by strong technical momentum, despite weak financial performance and unattractive valuation. The company’s high leverage and negative cash flows are areas of concern, but recent price momentum indicates investor interest.

To see Spark’s full report on CELU stock, click here.

More about Celularity

Average Trading Volume: 246,415

Technical Sentiment Signal: Buy

Current Market Cap: $78.55M

Find detailed analytics on CELU stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1